scholarly journals Bispecific antibodies with Fab-arms featuring exchanged antigen-binding constant domains

2021 ◽  
Vol 26 ◽  
pp. 100959
Author(s):  
Filippo Benedetti ◽  
Florian Stracke ◽  
Gerhard Stadlmayr ◽  
Katharina Stadlbauer ◽  
Florian Rüker ◽  
...  
2019 ◽  
Vol 117 (1) ◽  
pp. 292-299 ◽  
Author(s):  
Lynn E. Macdonald ◽  
Karoline A. Meagher ◽  
Matthew C. Franklin ◽  
Natasha Levenkova ◽  
Johanna Hansen ◽  
...  

We describe a Kappa-on-Heavy (KoH) mouse that produces a class of highly diverse, fully human, antibody-like agents. This mouse was made by replacing the germline variable sequences of both the Ig heavy-chain (IgH) and Ig kappa (IgK) loci with the human IgK germline variable sequences, producing antibody-like molecules with an antigen binding site made up of 2 kappa variable domains. These molecules, named KoH bodies, structurally mimic naturally existing Bence-Jones light-chain dimers in their variable domains and remain wild-type in their antibody constant domains. Unlike artificially diversified, nonimmunoglobulin alternative scaffolds (e.g., DARPins), KoH bodies consist of a configuration of normal Ig scaffolds that undergo natural diversification in B cells. Monoclonal KoH bodies have properties similar to those of conventional antibodies but exhibit an enhanced ability to bind small molecules such as the endogenous cardiotonic steroid marinobufagenin (MBG) and nicotine. A comparison of crystal structures of MBG bound to a KoH Fab versus a conventional Fab showed that the KoH body has a much deeper binding pocket, allowing MBG to be held 4 Å further down into the combining site between the 2 variable domains.


2004 ◽  
Vol 44 (supplement) ◽  
pp. S34
Author(s):  
T. Sagawa ◽  
M. Oda ◽  
H. Morii ◽  
H. Kozono ◽  
T. Azuma

Antibodies ◽  
2018 ◽  
Vol 7 (3) ◽  
pp. 29 ◽  
Author(s):  
Giovanni Magistrelli ◽  
Guillemette Pontini ◽  
Yves Poitevin ◽  
Pauline Malinge ◽  
Jérémie Bourguignon ◽  
...  

Bispecific antibodies (bsAbs) are often composed of several polypeptide chains that have to be expressed adequately to enable optimal assembly and yield of the bsAb. κλ bodies are a bispecific format with a native IgG structure, composed of two different light chains that pair with a common heavy chain. Introduction of non-optimal codons into the sequence of a particular polypeptide is an effective strategy for down modulating its expression. Here we applied this strategy but restricted the modification of the codon content to the constant domain of one light chain. This approach facilitates parallel optimization of several bsAbs by using the same modified constant domains. Partial sequence de-optimization reduced expression of the targeted polypeptide. Stable cell pools could be isolated displaying increased bispecific antibody titers as well as changes in the abundance of undesired by-products that require elimination during downstream processing. Thus, modulating the relative expression of polypeptides can have a significant impact on bsAb titer and product related impurities; which are important factors for large scale manufacturing for clinical supply.


1992 ◽  
Vol 29 (10) ◽  
pp. 1219-1227 ◽  
Author(s):  
W.Jeffrey Allard ◽  
Christine A. Moran ◽  
Eva Nagel ◽  
Geary Collins ◽  
Michael T. Largen

2010 ◽  
Vol 23 (4) ◽  
pp. 289-297 ◽  
Author(s):  
G. Wozniak-Knopp ◽  
S. Bartl ◽  
A. Bauer ◽  
M. Mostageer ◽  
M. Woisetschläger ◽  
...  

Author(s):  
Maximilian Woisetschläger ◽  
Florian Rüker ◽  
Geert C. Mudde ◽  
Gordana Wozniak-Knopp ◽  
Anton Bauer ◽  
...  

2018 ◽  
Vol 126 (2) ◽  
pp. 153-161 ◽  
Author(s):  
Aruto Sugiyama ◽  
Mitsuo Umetsu ◽  
Hikaru Nakazawa ◽  
Teppei Niide ◽  
Ryutaro Asano ◽  
...  

2014 ◽  
Vol 41 (5) ◽  
pp. 653-660 ◽  
Author(s):  
Ulrich H. Weidle ◽  
Roland E. Kontermann ◽  
Ulrich Brinkmann

Sign in / Sign up

Export Citation Format

Share Document